- Home
- SOPH vs TKNO Comparison
SOPH vs TKNO Comparison
Compare SOPH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- TKNO
- Stock Information
- Founded
- SOPH 2011
- TKNO 1996
- Country
- SOPH Switzerland
- TKNO United States
- Employees
- SOPH N/A
- TKNO N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- SOPH Health Care
- TKNO Health Care
- Exchange
- SOPH Nasdaq
- TKNO Nasdaq
- Market Cap
- SOPH 226.6M
- TKNO 390.7M
- IPO Year
- SOPH 2021
- TKNO 2021
- Fundamental
- Price
- SOPH $3.26
- TKNO $7.73
- Analyst Decision
- SOPH Strong Buy
- TKNO Buy
- Analyst Count
- SOPH 3
- TKNO 2
- Target Price
- SOPH $7.00
- TKNO $5.00
- AVG Volume (30 Days)
- SOPH 21.3K
- TKNO 195.0K
- Earning Date
- SOPH 11-05-2024
- TKNO 11-07-2024
- Dividend Yield
- SOPH N/A
- TKNO N/A
- EPS Growth
- SOPH N/A
- TKNO N/A
- EPS
- SOPH N/A
- TKNO N/A
- Revenue
- SOPH $64,488,000.00
- TKNO $36,347,000.00
- Revenue This Year
- SOPH $7.20
- TKNO $3.47
- Revenue Next Year
- SOPH $15.71
- TKNO $12.07
- P/E Ratio
- SOPH N/A
- TKNO N/A
- Revenue Growth
- SOPH 9.85
- TKNO N/A
- 52 Week Low
- SOPH $2.70
- TKNO $1.16
- 52 Week High
- SOPH $7.37
- TKNO $8.91
- Technical
- Relative Strength Index (RSI)
- SOPH 46.64
- TKNO 51.60
- Support Level
- SOPH $3.06
- TKNO $7.00
- Resistance Level
- SOPH $3.47
- TKNO $8.89
- Average True Range (ATR)
- SOPH 0.18
- TKNO 0.74
- MACD
- SOPH -0.00
- TKNO -0.09
- Stochastic Oscillator
- SOPH 45.45
- TKNO 38.24
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.